HIMALAYAS: a phase 3, randomized, open‐label, active‐controlled study of the efficacy and safety of roxadustat in the treatment of anemia in incident‐dialysis patients [TH‐OR021]
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.